BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33117550)

  • 1. COVID-19 Status, Symptom Burden, and Characteristics of Dialysis Patients Residing in Areas of Community Transmission: Research Letter.
    Gale J; Clark DA; Bohm C; Canney M; Davis I; LeBlanc JJ; Shorter AM; Suri RS; Vinson AJ; West KA; Tennankore KK
    Can J Kidney Health Dis; 2020; 7():2054358120964178. PubMed ID: 33117550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Province-Wide Prevalence Testing for SARS-CoV-2 of In-Center Hemodialysis Patients and Staff in Ontario, Canada: A Cross-Sectional Study.
    Sniekers DC; Jung JKH; Blake PG; Cooper R; Leis JA; Muller MP; Padure V; Holm P; Yeung A; Taji L; McFarlane P; Oliver MJ
    Can J Kidney Health Dis; 2021; 8():20543581211036213. PubMed ID: 34394945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    medRxiv; 2020 Oct; ():. PubMed ID: 33106813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Comorbidities, General Health Status, and Self-Care Self-Efficacy on COVID-19 Symptoms During the Omicron Wave.
    Jose MM; Feng J; Nguyen HT; Juneau C; Manakatt BM; Barnett J; Jones JL; Raji M
    Cureus; 2023 Nov; 15(11):e49176. PubMed ID: 38130505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Taste and Smell are Common Clinical Characteristics of Patients with COVID-19 in Somalia: A Retrospective Double Centre Study.
    Farah Yusuf Mohamud M; Garad Mohamed Y; Mohamed Ali A; Ali Adam B
    Infect Drug Resist; 2020; 13():2631-2635. PubMed ID: 32801800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.
    Wohl DA; Barzin AH; Napravnik S; Davy-Mendez T; Smedberg JR; Thompson CM; Ruegsegger L; Gilleskie M; Weber DJ; Whinna HC; Miller MB
    PLoS One; 2021; 16(12):e0260879. PubMed ID: 34890441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in COVID-19 symptoms and outcomes in people with kidney failure treated with dialysis: a prospective cohort study.
    Harrison TG; Tam TA; Elliott MJ; Ahmed SB; Riehl-Tonn V; Swamy AKR; Benham JL; Peterson J; MacRae JM
    J Nephrol; 2023 Apr; 36(3):851-860. PubMed ID: 36087218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System.
    Malden DE; Tartof SY; Ackerson BK; Hong V; Skarbinski J; Yau V; Qian L; Fischer H; Shaw SF; Caparosa S; Xie F
    JMIR Public Health Surveill; 2022 Dec; 8(12):e41529. PubMed ID: 36446133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom presentation of SARS-CoV-2-positive and negative patients: a nested case-control study among patients calling the emergency medical service and medical helpline.
    Moeller AL; Mills EHA; Collatz Christensen H; Gnesin F; Blomberg SNFN; Zylyftari N; Jensen B; Ringgren KB; Broccia MD; Bøggild H; Torp-Pedersen C
    BMJ Open; 2021 May; 11(5):e044208. PubMed ID: 34031110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Study of Symptomatology of COVID-19 Laboratory-Confirmed Cases at Tertiary Care Center: A Cross-Sectional Study.
    Dabhekar S; Basagoudanavar S; Bidkar V; Prathipati K; Sujiv A; Rathod BS; Gadwal D
    Cureus; 2022 Feb; 14(2):e22186. PubMed ID: 35308685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis.
    Bijur PE; Friedman BW; Baron SW; Ramasahayam A; Nerenberg R; Sharpe S; Goldstein DY; Esses D
    Am J Emerg Med; 2022 Apr; 54():274-278. PubMed ID: 35220142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Loss of Smell and/or Taste and other Otorhinolaryngology Symptoms in COVID-19 Patients.
    Shrestha I; Mishra A; Mishra A; Bista M; Acharya J
    Kathmandu Univ Med J (KUMJ); 2021; 19(74):173-179. PubMed ID: 34819431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington.
    Roxby AC; Greninger AL; Hatfield KM; Lynch JB; Dellit TH; James A; Taylor J; Page LC; Kimball A; Arons M; Munanga A; Stone N; Jernigan JA; Reddy SC; Lewis J; Cohen SA; Jerome KR; Duchin JS; Neme S
    JAMA Intern Med; 2020 Aug; 180(8):1101-1105. PubMed ID: 32437547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ear nose throat-related symptoms with a focus on loss of smell and/or taste in COVID-19 patients.
    Sakalli E; Temirbekov D; Bayri E; Alis EE; Erdurak SC; Bayraktaroglu M
    Am J Otolaryngol; 2020; 41(6):102622. PubMed ID: 32629147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of symptoms for pediatric SARS-CoV-2 infection in a primary care setting.
    Weng CH; Butt WWW; Brooks MB; Clarke C; Jenkins HE; Holland SD; Chiang SS
    PLoS One; 2021; 16(12):e0249980. PubMed ID: 34898635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.
    Karaarslan F; Demircioğlu Güneri F; Kardeş S
    Rheumatol Int; 2021 Jul; 41(7):1263-1271. PubMed ID: 33978818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In COVID-19 Patients, the Identified Gastrointestinal Symptoms in Tertiary Care Center of India.
    Murugesan M; Govindarajan R; Prakash L; Murugan CK; Jasmine JJ; Krishnasamy N
    Euroasian J Hepatogastroenterol; 2022; 12(1):24-30. PubMed ID: 35990860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.